Supply Issues Forma-Care (UK) Ltd Belted Pad CFP85091 (ICN 3274)

• The supply issue with belted pad products from Forma-Care (UK) Ltd is continuing.
• One product remains suspended and unavailable to order:
  • CFP85091- Belt product for moderate to heavy incontinence D16.
• One product code remains affected in total.
• Potential indirect alternative products are available to order through our online catalogue:
  • CFP1639 – Belt product for moderate to heavy incontinence D16
  • CFP4427 – Belt product for moderate to heavy incontinence D16.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is now anticipated to be resolved by 1 May 2026.

Change:

• The supplier Forma-Care (UK) Ltd has informed us of a supply issue with its Belt Pad products.
• One product code is affected:
  • CFP85091- Belt product for moderate to heavy incontinence D16.
• The supply issue is due to increased demand and lead times.

Impact:

• CFP85091 is currently suspended and unavailable to order.
• Potential indirect alternative products are available to order through our online catalogue:
  • CFP1639 – Belt product for moderate to heavy incontinence D16
  • CFP4427 – Belt product for moderate to heavy incontinence D16.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 14 April 2026.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative products.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.